Medical Management of Pituitary-Dependent Hyperadrenocorticism: Mitotane versus Trilostane

Pituitary-dependent hyperadrenocorticism is a common endocrine disorder in dogs in the United States. Once a diagnosis is established, a decision must be made whether or not to pursue treatment, and if so, which medication to use. Historically, mitotane (Lysodren, o,p'-DDD, Bristol-Myers Squibb...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Topics in companion animal medicine 2012-02, Vol.27 (1), p.25-30
1. Verfasser:	Reine, Nyssa J.
Format:	Artikel
Sprache:	eng
Schlagworte:	adrenal dependent hyperadrenocorticism Adrenal glands Diabetes Diarrhea Dogs Drug dosages Drug therapy Hypertension mitotane pituitary-dependent hyperadrenocorticism trilostane Urogenital system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!